CircMALAT1 promotes cancer stem‐like properties and chemoresistance via regulating Musashi‐2/c‐Myc axis in esophageal squamous cell carcinoma

Abstract The primary challenge in treating esophageal squamous cell carcinoma (ESCC) is resistance to chemotherapy. Cancer stem cell (CSC) is the root cause of tumor drug resistance. Therefore, targeting CSCs has been considered promising therapeutic strategy for tumor treatment. Here, we report tha...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Zitong Zhao, Yingni Deng, Jing Han, Liying Ma, Yumeng Zhu, Hua Zhang, Zhixu He, Yongmei Song
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Wiley 2024-06-01
coleção:	MedComm
Assuntos:	cancer stem cell (CSC) circMALAT1 drug resistance esophageal squamous cell carcinoma (ESCC) Musashi RNA binding protein 2 (MSI2)
Acesso em linha:	https://doi.org/10.1002/mco2.612
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!